QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.079319v1 313/3/1254    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, X. Articles by Van Deusen, J. Search for Related Content PubMed PubMed Citation Articles by Liu, X. Articles by Van Deusen, J.

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Use of a Physiologically Based Pharmacokinetic Model to Study the Time to Reach Brain Equilibrium: An Experimental Analysis of the Role of Blood-Brain Barrier Permeability, Plasma Protein Binding, and Brain Tissue Binding

Pharmacokinetics, Dynamics, and Metabolism, Pfizer Global Research and Development, Groton, Connecticut

This study was designed 1) to examine the effects of blood-brain barrier (BBB) permeability [quantified as permeability-surface area product (PS)], unbound fraction in plasma (f_u,plasma), and brain tissue (f_u,brain) on the time to reach equilibrium between brain and plasma and 2) to investigate the drug discovery strategies to design and select compounds that can rapidly penetrate the BBB and distribute to the site of action. The pharmacokinetics of seven model compounds: caffeine, CP-141938 [methoxy-3-[(2-phenyl-piperadinyl-3-amino)-methyl]-phenyl-N-methyl-methane-sulfonamide], fluoxetine, NFPS [N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine], propranolol, theobromine, and theophylline in rat brain and plasma after subcutaneous administration were studied. The in vivo log PS and log f_u,brain calculated using a physiologically based pharmacokinetic model correlates with in situ log PS (R² = 0.83) and in vitro log f_u,brain (R² = 0.69), where the in situ PS and in vitro f_u,brain was determined using in situ brain perfusion and equilibrium dialysis using brain homogenate, respectively. The time to achieve brain equilibrium can be quantitated with a proposed parameter, intrinsic brain equilibrium half-life [t_1/2eq,in = V_bln2/(PS · f_u,brain)], where V_b is the physiological volume of brain. The in vivo log t_1/2eq,in does not correlate with in situ log PS (R² < 0.01) but correlates inversely with log(PS · f_u,brain) (R² = 0.85). The present study demonstrates that rapid brain equilibration requires a combination of high BBB permeability and low brain tissue binding. A high BBB permeability alone cannot guarantee a rapid equilibration. The strategy to select compounds with rapid brain equilibration in drug discovery should identify compounds with high BBB permeability and low nonspecific binding in brain tissue.

Address correspondence to: Dr. Xingrong Liu, Pfizer Global Research and Development, MS 8220-4167, Eastern Point Road, Groton, CT 06340. E-mail: xingrong.liu{at}pfizer.com

This article has been cited by other articles:

				X. Liu, C. Chen, and B. J. Smith Progress in Brain Penetration Evaluation in Drug Discovery and Development J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 349 - 356. [Abstract] [Full Text] [PDF]

				E. Fornaro, D. Li, J. Pan, and J. Belik Prenatal Exposure to Fluoxetine Induces Fetal Pulmonary Hypertension in the Rat Am. J. Respir. Crit. Care Med., November 15, 2007; 176(10): 1035 - 1040. [Abstract] [Full Text] [PDF]

				S. G. Summerfield, K. Read, D. J. Begley, T. Obradovic, I. J. Hidalgo, S. Coggon, A. V. Lewis, R. A. Porter, and P. Jeffrey Central Nervous System Drug Disposition: The Relationship between in Situ Brain Permeability and Brain Free Fraction J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 205 - 213. [Abstract] [Full Text] [PDF]

				X. Liu, B. J. Smith, C. Chen, E. Callegari, S. L. Becker, X. Chen, J. Cianfrogna, A. C. Doran, S. D. Doran, J. P. Gibbs, et al. Evaluation of Cerebrospinal Fluid Concentration and Plasma Free Concentration As a Surrogate Measurement for Brain Free Concentration Drug Metab. Dispos., September 1, 2006; 34(9): 1443 - 1447. [Abstract] [Full Text] [PDF]

				S. Becker and X. Liu EVALUATION OF THE UTILITY OF BRAIN SLICE METHODS TO STUDY BRAIN PENETRATION Drug Metab. Dispos., May 1, 2006; 34(5): 855 - 861. [Abstract] [Full Text] [PDF]

				S. G. Summerfield, A. J. Stevens, L. Cutler, M. del Carmen Osuna, B. Hammond, S.-P. Tang, A. Hersey, D. J. Spalding, and P. Jeffrey Improving the in Vitro Prediction of in Vivo Central Nervous System Penetration: Integrating Permeability, P-glycoprotein Efflux, and Free Fractions in Blood and Brain J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1282 - 1290. [Abstract] [Full Text] [PDF]